Jeffrey V. Ravetch is Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX). They have made 1 open-market trade across 1 company since 2016, most recently 2017-04-02.
CIK 0001612051
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MBVX | 3,086 | $4K |
Shares reported on the most recent Form 4, priced at the 2017-04-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBVX | SELL | 2016-03-24 | 2016-03-25 | $0.60 | $79K | +4.5% | -4.8% | -4.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.